An AMPA receptor potentiator modulates hippocampal expression of BDNF: an in vivo study

被引:103
作者
Mackowiak, M
O'Neill, MJ
Hicks, CA
Bleakman, D
Skolnick, P
机构
[1] Polish Acad Sci, Inst Pharmacol, Dept Pharmacol, Lab Pharmacol & Brain Biostruct, PL-31343 Krakow, Poland
[2] Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA
[3] Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA
[4] Eli Lilly & Co, Lilly Res Ctr Ltd, Windlesham GU20 6PH, Surrey, England
[5] DOV Pharmaceut, Hackensack, NJ 07601 USA
关键词
BDNF; AMPA receptor; LY404187; LY451646; rat; immunocytochemistry; mRNA;
D O I
10.1016/S0028-3908(02)00066-7
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
AMPA receptor activation has been demonstrated to increase the neuronal expression of brain derived neurotrophic factor (BDNF). In the present study, we investigated the effect of a novel AMPA receptor potentiator (LY404187) and its active isomer (LY451646) on the expression of BDNF protein and mRNA, as well as TrkB mRNA in rat hippocampus. LY404187 administered for 7 days (1 mg/kg) significantly increased the number of BDNF immunopositive cells in the dentate gyrus, but not other hippocampal subfields. Chronic treatment (7 days) with LY451646 (0.5 mg/kg, comparable to 1 mg/kg of LY404187) increased the level of both BDNF and TrkB mRNA expression in the dentate gyrus, CA3 and CA4 of the hippocampus. However, chronic treatment with lower doses of LY451646 (0.125 and 0.25 mg/kg) decreased the level of BDNF and TrkB mRNA in hippocampus, whilst the hi-hest used dose of LY451646 (I mg/kg) had no effect on BDNF and TrkB mRNA in hippocampus. In contrast, acute treatment with LY451646 produced an increase in BDNF mRNA levels at doses of 0.125 and 0.25 mg/kg in the hippocampus (CA4, CA3 and dentate gyrus, but not in CA1). LY451646 at 0.5 mg/kg had no effect, but at 1.0 mg/ka decreased the level of BDNF mRNA in hippocampus. Acute treatment with LY451646 did not affect the TrkB receptor mRNA levels in hippocampus. Our results demonstrate that biarylpropylsulfonamide AMPA receptor potentiators are capable of modulating the expression of BDNF and TrkB mRNA in a dose- and time-dependent manner. The increase in both BDNF protein and mRNA expression in the dentate Gyrus but not in CA1 indicates a specific role of AMPA receptors in the regulation of BDNF expression in this hippocampal subfield. The regulation of BDNF expression by biarylpropylsulfonamids such as LY451646 may have important therapeutical implications for this class of molecule in the treatment of depression and other CNS disorders. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1 / 10
页数:10
相关论文
共 41 条
[1]   Neurotrophins and depression [J].
Altar, CA .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1999, 20 (02) :59-61
[2]  
[Anonymous], RAT BRAIN STEREOTAXI
[3]   Intra- and interstrain differences in models of "behavioral despair" [J].
Bai, F ;
Li, X ;
Clay, M ;
Lindstrom, T ;
Skolnick, P .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2001, 70 (2-3) :187-192
[4]   LY392098, a novel AMPA receptor potentiator: electrophysiological studies in prefrontal cortical neurons [J].
Baumbarger, P ;
Muhlhauser, M ;
Yang, CR ;
Nisenbaum, ES .
NEUROPHARMACOLOGY, 2001, 40 (08) :992-1002
[5]   Neuropharmacology of AMPA and kainate receptors [J].
Bleakman, D ;
Lodge, D .
NEUROPHARMACOLOGY, 1998, 37 (10-11) :1187-1204
[6]   AMPA receptors: Molecular and functional diversity [J].
Borges, K ;
Dingledine, R .
GLUTAMATE SYNAPSE AS A THERAPEUTICAL TARGET: MOLECULAR ORGANIZATION AND PATHOLOGY OF THE GLUTAMATE SYNAPSE, 1998, 116 :153-170
[7]   Regulation of GluR2 promoter activity by neurotrophic factors via a neuron-restrictive silencer element [J].
Brené, S ;
Messer, C ;
Okado, H ;
Hartley, M ;
Heinemann, SF ;
Nestler, EJ .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2000, 12 (05) :1525-1533
[8]   Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication [J].
Chen, B ;
Dowlatshahi, D ;
MacQueen, GM ;
Wang, JF ;
Young, LT .
BIOLOGICAL PSYCHIATRY, 2001, 50 (04) :260-265
[9]   Neural plasticity to stress and antidepressant treatment [J].
Duman, RS ;
Malberg, J ;
Thome, J .
BIOLOGICAL PSYCHIATRY, 1999, 46 (09) :1181-1191
[10]   Pharmacological effects of AMPA receptor potentiators LY392098 and LY404187 on rat neuronal AMPA receptors in vitro [J].
Gates, M ;
Ogden, A ;
Bleakman, D .
NEUROPHARMACOLOGY, 2001, 40 (08) :984-991